Northern Gritstone invests in early-stage, IP-rich science and technology spinouts originating from the 'Northern Arc' universities of Leeds, Manchester, Sheffield, and Liverpool. Operating under a 'profit with purpose' philosophy, the fund aims to deliver strong financial returns while driving regional economic impact and job creation in the North of England.
About Northern Gritstone
Northern Gritstone is a UK investment firm focused on commercializing science and technology coming out of the Northern England research universities, particularly Manchester, Leeds, and Sheffield, with a thesis around backing university spinouts and applied-research companies. The firm’s structure is closer to a deeptech and life-sciences focused regional capital provider than a generalist venture fund. Healthcare exposure is meaningful, particularly in life sciences, medtech, and AI-for-biology categories, where the Northern English research base is genuinely strong, including in cancer research, regenerative medicine, and clinical AI. AI focus is real and applied, particularly where AI sits adjacent to scientific research. Stage is typically Seed and Series A, with checks plausibly in the GBP 500K to GBP 5M range, often leading or strongly co-investing in spinout rounds with capacity for follow-on. This is the wrong door for software-only digital health unconnected to Northern England research, US-only commercialization plays, or capital-light services businesses. It is a strong fit for university spinouts and applied-research healthcare companies anchored in Manchester, Leeds, Sheffield, and the broader Northern English research base. Entry path is the website contact and warm introductions through technology transfer offices at the relevant universities; founders should be ready to discuss specific research provenance, IP position, and clinical translation pathways.
Founder reviews
Other portfolio companies
Companies in Northern Gritstone's portfolio not currently in our directory.
- Apini Therapeutics · 2025
- Crucible Therapeutics · 2023
- adsilico · 2024
- IVFmicro · 2025
- Pencil Biosciences · 2023
- QV Bioelectronics
- Imperagen · 2022
- Silveray · 2026
Team
Pitch / review this investor
Have you raised from Northern Gritstone? Founders only — share your honest experience (anonymous OK, moderated before publishing).